Clinical Trial Update: An Extension Study to Evaluate Safety and Tolerability of Ranibizumab in Macular Edema Secondary to Retinal Vein Occlusion (Cohort 2) [NA]

View source ↗

Summary

An extension study to evaluate the safety and tolerability of ranibizumab for macular edema due to retinal vein occlusion has completed; results were posted in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Macular Edema
• Retinal Vein Occlusion

Drugs mentioned

• Lucentis (ranibizumab)

Snippet

Sponsor: Genentech, Inc. | Conditions: Macular Edema, Retinal Vein Occlusion | NA | Status: COMPLETED | Results posted: 2012-01-10